The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Condyline 5 mg/ml Cutaneous Solution



Takeda Products Ireland LtdPA2229/006/001

Main Information

Trade NameCondyline 5 mg/ml Cutaneous Solution
Active SubstancesPodophyllotoxin
Dosage FormCutaneous solution
Licence HolderTakeda Products Ireland Ltd
Licence NumberPA2229/006/001

Group Information

ATC CodeD06BB Antivirals
D06BB04 podophyllotoxin

Status

License statusAuthorised
Licence Issued11/04/1988
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back